Efficacy of alemtuzumab in relapsing-remitting multiple sclerosis (RRMS) patients with highly active disease despite therapy

被引：0

作者：

Confavreux, C. ^{[1
]}

Twyman, C. L. ^{[2
]}

Arnold, D. ^{[3
]}

Cohen, J. ^{[4
]}

Coles, A. J. ^{[5
]}

Fox, E. J. ^{[6
]}

Hartung, H-P. ^{[7
]}

Havrdova, E. ^{[8
,9
]}

Selmaj, K. ^{[10
]}

Weiner, H. ^{[11
]}

Miller, T. ^{[12
]}

Lake, S. L. ^{[13
]}

Margolin, D. H. ^{[13
]}

Panzara, M. ^{[13
]}

Compston, A. ^{[5
]}

机构：

[1] Univ Lyon 1, F-69365 Lyon, France

[2] Associates Neurol, Lexington, KY USA

[3] NeuroRx Res Inc, Montreal, PQ, Canada

[4] Cleveland Clin Fdn, Cleveland, OH 44195 USA

[5] Univ Cambridge, Sch Med, Cambridge, England

[6] Univ Texas Med Branch, Round Rock, TX USA

[7] Univ Dusseldorf, D-40225 Dusseldorf, Germany

[8] Charles Univ Prague, Fac Med 1, Prague, Czech Republic

[9] Cent Mil Hosp, Prague, Czech Republic

[10] Med Univ Lodz, Lodz, Poland

[11] Brigham & Womens Hosp, Boston, MA 02115 USA

[12] Adv Neurol Colorado, Ft Collins, CO USA

[13] Genzyme, Cambridge, MA USA

来源：

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：88 / 88

页数：1